$0.77
-0.03 (-3.43%)
Open$0.81
Previous Close$0.80
Day High$0.86
Day Low$0.77
52W High$23.94
52W Low$0.76
Volume—
Avg Volume42.1K
Market Cap1.73M
P/E Ratio—
EPS$-10.91
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,445.6% upside
Current
$0.77
$0.77
Target
$19.68
$19.68
$12.72
$19.68 avg
$25.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 346.9K | 1.73M | 478.0K |
| Net Income | -50,913,715 | -228,426,438 | -25,168 |
| Profit Margin | -14,677.7% | -13,943.8% | -5.3% |
| EBITDA | -47,745,962 | -226,114,974 | -28,783 |
| Free Cash Flow | — | — | -23,138 |
| Rev Growth | -79.9% | -79.9% | +3.1% |
| Debt/Equity | 2.46 | 2.46 | 0.11 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |